Stock INNO INNOCAN PHARMA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart InnoCan Pharma Corporation

Equities

INNO

CA45783P1027

Delayed Canadian Securities Exchange
Other stock markets
 07:00:00 04/06/2024 pm IST 		5-day change 1st Jan Change
0.28 CAD 0.00% Intraday chart for InnoCan Pharma Corporation -3.45% -9.68%
27/05 InnoCan Pharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
27/05 Innocan Pharma Reports First Quarter 2024 Results With Revenue Growth Of Over 4X To $6.8 Million MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
INNOCAN PHARMA CORPORATION
Other Pharmaceuticals
0.00%-3.45%-9.68%+7.69% - 5.77Cr - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. INNO Stock
  4. Charts InnoCan Pharma Corporation
  5. Comparison Chart